FDA Investigator Vanessa Y Gelsey, PhD

Vanessa Y Gelsey, PhD has inspections in 2 countries as of 15 Nov 2023. Vanessa Y Gelsey, PhD has collaborated with a combinined 2938 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
107
Last Inspection Date:
15 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada
Co-Investigator(s):
Aaron J Poloni, Abby M Miller, Alan D Grupe, Alexander M Kay, Andrew "Drew" Haack, PhD, Andrew Haack, PhD, Andrew K Haack, PhD, Anita Narula, PhD, Astrida B Mattson, Ava M Bowman, Barbara Janine Breithaupt, Betsy C Galliher, Brenda K Alford, Brenda L Reihing, Brent W Higgs, Brian Janelsins, PhD, Bruce R Burrell, Bryan Baker, Camille Bennett Hoffman, Carl A Anderson, CDR Donald Ertel, Ce'nedra M Martin, Celeta S Coves, Charles Yuanchia Kuo, PhD, Chava Kimchi Sarfaty, PhD, Chet A Fitzgerald, Christopher R Czajka, Christopher S Genther, Clinton R Vanblaricom, Cynthia L Gorveatt, Cynthia L Rakestraw, Dan G Eisenbrey, Daniel A Congdon, David A Quale, Dawn E Barkans, Deborah A Nebenzahl, Deborah M Trout, Dennis R Hudson, Devon M Shoop, Diane Hall, Dianna D Wardlow Dotter, Dirk L Lincoln, Dolores E Price, Edward D Harris, Elmina E Akwo, Eric C Milstead, Gerard Pde Leon, Gina C Collins, Gloria A Milster, Gloria J Baca, MS, Harmon M Blanch, Hasan A Irier, PhD, Heika R Tait, Hugh Grimoldby, Ismael Olvera, IV, Jane M Kreis, Jean Brewer, Jean C Colon Lopez, Jean R Mccurry, Jeanne M Weishaar, Jeffrey N Gerdes, Jessica B Clark, Jessica L Kocian, Jessica L Walters Moell, Jessie J Deloach, Jinkee Mvila Binayug, Joan Johnson, John W Banks, Jonathan T Little, Joseph A Dinardo, Julian C Hanson, Julie Scoma, Kaarin M Slotte, Karen M Cooper, Katherine L Arnold, Kathryn A Krentz, Kathryn E King, Kelly D Moore, Kenneth O Gee, PhD, Kimberly A Dux, Kimberly J Proctor Jones, Kip J Hanks, Lance W Bohm, Lauren E Swantko, Lawrence Y Lee, PhD, Leeterry Moore, Linda S Leja, Lisa A Bowden, Lisa K Capron, Lisa M Althar, Lori J Silverstein, LTJG Bradley E Benasutti, Marc A Jackson, Jr, Margaret M Annes, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mark E Imsland, Mark E Moen, Mark W Babbitt, Marlene L Davis, Marsha L Mccauley, Matthew R Barr, Michael J Donovan, Michael S Araneta, Michael S Valenzuela, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Nancy A Saxenian Emmons, Nancy E Byerly, Nancy E Doyle, Nataniel Phillips Sylvain, PhD, Orval D Mcintire, Ounchith J Phabmixay, Paul F Rader, Paul M Chefor, Peter Kessler, PhD, Peter W Gothro, Philippe A Cornet, Prabhu P Raju, Rabia Ballica, PhD, Rebecca T Davis, Richard A Martin, Richard Heath Coats, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Riley Meyers, Robert B Shibuya, MD, Robert D Tollefsen, Rocco C Black, Roger F Zabinski, S Lori Brown, PhD MPH, Sandra K Wangen, Sangeeta M Khurana, PhD, Sarah J Cullen, Savini, Shahriar Rahmani, Shannon J Hall, Sharon I Gundersen, Shelagh D Schopen, Shelley H Beausoleil, Sherri N Rohlf, MD, Sherryl Stoltenow, Sripal R Mada, PhD, Stanley B Eugene, BS, BME, State Agency, Stephanie J Shaw, Stephen R Souza, Sunitha K Rajaram, PhD, Tara A Marshall, Teegan Dellibovi Ragheb, PhD, Thomas C Mclean, CFS, Travis S Bradley, V Teres Speer, Vanessa Y Jacobs, Vining, Vitaliy N Guyvan, Wayne E Seifert, Yideng Liang, Yuan Chia Kuo, Zhong Li, PhD

Vanessa Y Gelsey, PhD's Documents

Publish Date Document Type Title
June, 2011 FDA 483 Snokist Growers - Form 483, 2011-06-02
June, 2012 FDA 483 International Cellular Medicine Society IRB - Form 483, 2012-06-19
June, 2011 FDA 483 Response Snokist Growers - Form 483R, 2011-06-22
April, 2016 FDA 483 AGC Biologics, Inc. - Form 483, 2016-04-22
September, 2013 EIR Biomat USA, Inc. - EIR, 2013-09-23
September, 2013 FDA 483 Biomat USA, Inc. - Form 483, 2013-09-23
March, 2012 FDA 483 Arifulla Khan MD - Form 483, 2012-03-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more